The invention relates to the use of substituted 4-amino-1-phenylbutan-2-ol compounds in the form of their racemates, enantiomers, diastereomers or corresponding bases or corresponding salts of physiologically acceptable acids as regulators for the nociceptin/orphanin-FQ ligand ORL1 receptor system and for the production of medicaments.

 
Web www.patentalert.com

< Pyranoindoles for treating glaucoma

< Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders

> C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals

> Pro1410 polypeptides
~ 00245